Company intelligence / Profile preview

Pyramis Global Advisors

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Pyramis Global Advisors was an institutional asset management business within Fidelity Investments focused on investment products and solutions for institutional clients. The firm offered strategies across major asset classes including equities, fixed income, alternatives, and real estate-related investments. It was not a biotech, pharma, or healthcare operating company, although its investment teams covered healthcare and biotechnology securities as part of public-market investing activities. The Pyramis name was retired in November 2015, when the business was renamed Fidelity Institutional Asset Management (FIAM).

Industry: Investors

Beyond the preview

Go deeper on Pyramis Global Advisors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyramis Global Advisors.

Explore the full profile